These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
592 related items for PubMed ID: 17929294
1. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, Yokoyama M, Honda M, Zen Y, Nakanuma Y, Miyamoto K, Kaneko S. Hepatology; 2007 Nov; 46(5):1392-403. PubMed ID: 17929294 [Abstract] [Full Text] [Related]
2. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. Ahn J, Cho I, Kim S, Kwon D, Ha T. J Hepatol; 2008 Dec; 49(6):1019-28. PubMed ID: 18930334 [Abstract] [Full Text] [Related]
3. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC. J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649 [Abstract] [Full Text] [Related]
4. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S. Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878 [Abstract] [Full Text] [Related]
5. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443 [Abstract] [Full Text] [Related]
6. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. Kubota N, Kado S, Kano M, Masuoka N, Nagata Y, Kobayashi T, Miyazaki K, Ishikawa F. Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112 [Abstract] [Full Text] [Related]
7. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, Renner EL, Clavien PA. Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180 [Abstract] [Full Text] [Related]
8. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Sugimoto H, Okada K, Shoda J, Warabi E, Ishige K, Ueda T, Taguchi K, Yanagawa T, Nakahara A, Hyodo I, Ishii T, Yamamoto M. Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G283-94. PubMed ID: 19926817 [Abstract] [Full Text] [Related]
9. The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis. Ando H, Takamura T, Matsuzawa-Nagata N, Shima KR, Nakamura S, Kumazaki M, Kurita S, Misu H, Togawa N, Fukushima T, Fujimura A, Kaneko S. Biochem Biophys Res Commun; 2009 Mar 13; 380(3):684-8. PubMed ID: 19285022 [Abstract] [Full Text] [Related]
10. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. Shindo N, Fujisawa T, Sugimoto K, Nojima K, Oze-Fukai A, Yoshikawa Y, Wang X, Yasuda O, Ikegami H, Rakugi H. J Hepatol; 2010 Jun 13; 52(6):903-12. PubMed ID: 20392512 [Abstract] [Full Text] [Related]
11. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Uno M, Kurita S, Misu H, Ando H, Ota T, Matsuzawa-Nagata N, Kita Y, Nabemoto S, Akahori H, Zen Y, Nakanuma Y, Kaneko S, Takamura T. Hepatology; 2008 Jul 13; 48(1):109-18. PubMed ID: 18571789 [Abstract] [Full Text] [Related]
12. Perinatal exposure to bisphenol A exacerbates nonalcoholic steatohepatitis-like phenotype in male rat offspring fed on a high-fat diet. Wei J, Sun X, Chen Y, Li Y, Song L, Zhou Z, Xu B, Lin Y, Xu S. J Endocrinol; 2014 Sep 13; 222(3):313-25. PubMed ID: 25112833 [Abstract] [Full Text] [Related]
13. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G. Transl Res; 2012 Jun 13; 159(6):477-86. PubMed ID: 22633099 [Abstract] [Full Text] [Related]
14. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin. Ni Y, Nagashimada M, Zhan L, Nagata N, Kobori M, Sugiura M, Ogawa K, Kaneko S, Ota T. Endocrinology; 2015 Mar 13; 156(3):987-99. PubMed ID: 25562616 [Abstract] [Full Text] [Related]
15. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T, Hibi T. Hepatology; 2008 Aug 13; 48(2):458-73. PubMed ID: 18666257 [Abstract] [Full Text] [Related]
16. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM. Hepatology; 2007 Jun 13; 45(6):1366-74. PubMed ID: 17476695 [Abstract] [Full Text] [Related]
18. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model. Matsunami T, Sato Y, Ariga S, Sato T, Shimomura T, Kashimura H, Hasegawa Y, Yukawa M. Metabolism; 2011 Jun 15; 60(6):805-14. PubMed ID: 20846698 [Abstract] [Full Text] [Related]
19. Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis. Bloomer SA, Olivier AK, Bergmann OM, Mathahs MM, Broadhurst KA, Hicsasmaz H, Brown KE. Cell Biochem Funct; 2016 Dec 15; 34(8):628-639. PubMed ID: 27935134 [Abstract] [Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC. J Gastroenterol Hepatol; 2008 Feb 15; 23(2):267-75. PubMed ID: 17868330 [Abstract] [Full Text] [Related] Page: [Next] [New Search]